41results about How to "Speed recovery" patented technology

A “row-diagonal” (R-D) parity technique reduces overhead of computing diagonal parity for a storage array adapted to enable efficient recovery from the concurrent failure of two storage devices in the array. The diagonal parity is computed along diagonal parity sets that collectively span all data disks and a row parity disk of the array. The parity for all of the diagonal parity sets except one is stored on the diagonal parity disk. The R-D parity technique provides a uniform stripe depth and an optimal amount of parity information.

A method of inserting and positioning an intervertebral spacer is provided. The spacer includes a longitudinal axis, an on-axis interface coincident with or parallel to the longitudinal axis, and an off-axis interface angled to the longitudinal axis. The spacer's front end may be curved. The method may include inserting the spacer into the disc space utilizing a tool to engage an on-axis interface and then to engage one or more of the off-axis interfaces, which may be used for further modification of the spacer. The tool is moved substantially along a single insertion direction, which may be substantially parallel to a posterior-anterior axis of the disc space. The method may result in the longitudinal axis of the spacer being perpendicular to the insertion direction, or substantially parallel to a medial-lateral axis of the disc space. The spacer may also be positioned in an anterior aspect of the disc space.

A device for mixing and delivering a mixture of fluids to a target site includes a tube for containing the mixture. A compressible auger for mixing the fluids is movably disposed within the tube, one end of the auger being free at the distal end of the tube. A plunger is also movable within the tube in communication with the other end of the auger. When the plunger is moved axially within the tube the auger also moves axially and the auger is compressed to dispense the fluid. The mixing and delivery device can be used with an apparatus for the arthroscopic delivery of a tissue repair material to a repair site. The apparatus includes a first sheath and a second sheath removably attached to the first sheath for delivering the tissue repair material to the repair site.

A passive motion exercise and / or treatment apparatus is provided which includes a main support assembly for supporting at least the head and torso of a user. The main assembly includes three support members which, in one mode of operation, are disposed in a common plane. The second and third members are movably connected to the first, backrest support member and are movable relative thereto so as to respectively provide passive movement of both the head and, and the lumbar region, of a user. Cervical side bending and rotational movements and lumbar side bending and rotational movements can all be provided. A separable leg support assembly is adjustable to support the calves of the user in a plane elevated with respect to the common plane while the apparatus provides the aforementioned passive body movements.

A multi-wing, multi-engine, multi-hull amphibious aircraft is disclosed. In the illustrative embodiment, the aircraft has an open frame structure without a fuselage.

A passive motion exercise and / or treatment apparatus is provided which includes a main support assembly for supporting at least the head and torso of a user. The main assembly includes three support members which, in one mode of operation, are disposed in a common plane. The second and third members are movably connected to the first member, which is a backrest support member, and are movable relative thereto so as to respectively provide passive movement of both the head and, and the lumbar region, of a user. Cervical side bending and rotational movements and lumbar side bending and rotational movements can all be provided. A separable leg support assembly is adjustable to support the calves of the user in a plane elevated with respect to the common plane while the apparatus provides the aforementioned passive body movements.

An arm cradle for holding and stabilizing an arm of a post-operative shoulder surgery patient is provided. The arm cradle has a cradle body having a first concave section adapted to accept at least a portion of an upper arm of a patient and a second concave section adapted to accept at least a portion of a lower arm of the patient. The first concave section and the second concave section may be arranged at an obtuse angle with respect to one another. A fabric cover may be provided for the cradle body. One or more straps may be affixed to one of the cradle body or the fabric cover and used to secure the arm cradle to the patient and / or to secure the arm of the patient in the arm cradle.

The present invention provides improved methods and pharmaceutical compositions for enhancing stem cell engraftment, comprising the administration of an effective amount of a modulator of RhoGTPases.

The present invention relates to a method of treating exercise-induced joint pain in arthritis-free mammals by the administration of undenatured Type II collagen.

A joint health exercise device and system to exercise the knee and shoulder joints of the body after an injury or surgery to the joints of the knee and shoulder and to tone and exercise the healthy joints of knees and shoulders. Use of the joint health exercise device of the invention reduces pain and swelling of the joints after an injury or surgery, decreases post surgical scar tissue formation and increases the range of motion of the shoulders, shoulder flexion, abduction, scaption and extension and speeds up functional recovery time of the knees and legs to facilitate standing, sitting and walking with the least restrictive assistive device or no assistive device at all. The joint health exercise device of the invention is light weight, portable and easy to use at home or when traveling.

The present invention relates to a method of treating exercise-induced joint pain in arthritis-free mammals by the administration of undenatured Type II collagen.

The present invention includes a support system for surgical patients, a convertible support for surgical patients, and a method for providing a convertible support for surgical patients. The support system comprises an arm cradle adapted to hold an arm of a patient at an angle when the patient is in a supine position and a side bolster adapted to be positioned against a side of a patient opposite the arm cradle. The side bolster is adapted to stabilize the patient in the supine position. The arm cradle is adapted to hold an arm of a patient at an angle conducive to recovery from shoulder surgery when the patient is in a supine position. The arm cradle is also adapted to be worn as a sling when the patient is ambulatory. The arm cradle, side bolster, and an optional head support may be secured to a mat in a temporary manner.

A multi-wing, multi-engine, multi-hull amphibious aircraft is disclosed. In the illustrative embodiment, the aircraft has an open frame structure without a fuselage.

An arm cradle for holding and stabilizing an arm of a post-operative shoulder surgery patient is provided. The arm cradle has a cradle body having a first concave section adapted to accept at least a portion of an upper arm of a patient and a second concave section adapted to accept at least a portion of a lower arm of the patient. The first concave section and the second concave section may be arranged at an obtuse angle with respect to one another. A fabric cover may be provided for the cradle body. One or more straps may be affixed to one of the cradle body or the fabric cover and used to secure the arm cradle to the patient and / or to secure the arm of the patient in the arm cradle.

A roll-on product, including magnesium hydroxide; propanediol; glycerin and glycine soja (soybean), is advantageously used as a deodorant and / or for transdermal magnesium delivery to the human body. Combinations of a magnesium source (especially magnesium hydroxide), with propanediol, and in some formulations with glycerin and glycine soja (soybean) are advantageous for transdermal delivery of magnesium to the body via a roll-on product, a stick, a spray, a lotion, gel, cream, etc. Magnesium deficiency is addressed via products easily used by an ordinary consumer for dermal application.

Abstract of the DisclosureAn orthopaedic brace includes a strut length adjustment assembly to change the operable length of the strut for sizing the brace on a patient without the need for special tools or cutting of the strut. The adjustment assembly includes a biased adjustment mechanism that coacts with a plurality of notches in the strut to variably set / position the strut relative to the adjustment assembly to set the struts length. Each upper and lower strut preferably includes a strut length adjustment assembly to independently set the length of each strut. The strut length adjustment assembly retains a strut and includes a strap retention mechanism that is configured to releasably engage the strap.

A roll-on product, including magnesium hydroxide; propanediol; glycerin and glycine soja (soybean), is advantageously used as a deodorant and / or for transdermal magnesium delivery to the human body. Combinations of a magnesium source (especially magnesium hydroxide), with propanediol, and with glycerin and glycine soja (soybean) are advantageous for transdermal delivery of magnesium to the body via a roll-on product, a stick, a spray, a lotion, etc. Magnesium deficiency is addressed via products easily used by an ordinary consumer for dermal application.

A roll-on product, including magnesium hydroxide; propanediol; glycerin and glycine soja (soybean), is advantageously used as a deodorant and / or for transdermal magnesium delivery to the human body. Combinations of a magnesium source (especially magnesium hydroxide), with propanediol, and with glycerin and glycine soja (soybean) are advantageous for transdermal delivery of magnesium to the body via a roll-on product, a stick, a spray, a lotion, etc. Magnesium deficiency is addressed via products easily used by an ordinary consumer for dermal application.

Novel growth peptides derived from protein factors having molecular weights of about 22 and 45 kDa stimulate mitogenic activity of epithelial, but not fibroblastic cells, in particular, kidney epithelial cells. A source of the factors is scrape-wounded kidney epithelial cells in culture. Synthetic peptides having sixteen amino acids or less, in particular a hexapeptide, YPQGNH (SEQ ID NO: 2) maintain the mitogenic activity. The peptide AQPYPQGNHEASYG (14-Ser) (SEQ ID NO: 15) is effective in reversing acute renal failure in animals. The growth-promoting characteristics of the 22 and 45 kDa proteins and the peptides are useful in treating and diagnosing patients with kidney disease. Nucleotide sequences that encode the factor are useful to develop probes to locate similar factors, to identify genetic disorders involving the factor, and to produce the factor by genetic recombinant methods. The nucleotide sequences and fragments thereof, are also useful for diagnosis and treatment of kidney disorders.

Compositions and methods for aiding Phase 3 recovery from post anesthesia and / or post colonoscopy procedure symptoms are disclosed.

Novel growth peptides derived from protein factors having molecular weights of about 22 and 45 kDa stimulate mitogenic activity of epithelial, but not fibroblastic cells, in particular, kidney epithelial cells. A source of the factors is scrape-wounded kidney epithelial cells in culture. Synthetic peptides having sixteen amino acids or less, in particular a hexapeptide, YPQGNH (SEQ ID NO: 2) maintain the mitogenic activity. The peptide AQPYPQGNHEASYG (14-Ser) (SEQ ID NO: 15) is effective in reversing acute renal failure in animals. The growth-promoting characteristics of the 22 and 45 kDa proteins and the peptides are useful in treating and diagnosing patients with kidney disease. Nucleotide sequences that encode the factor are useful to develop probes to locate similar factors, to identify genetic disorders involving the factor, and to produce the factor by genetic recombinant methods. The nucleotide sequences and fragments thereof, are also useful for diagnosis and treatment of kidney disorders.

The invention discloses a nodular cast iron pipe die which comprises a supporting base, a first annular guide rail and a cast iron pipe die body. The first annular guide rail is connected to the supporting base, the cast iron pipe die is horizontally inserted into the first annular guide rail in a penetrating mode, and the rear end of the cast iron pipe die is rotationally connected into the first annular guide rail. A rotating speed reduction preventing mechanism is connected between the cast iron pipe die and the supporting base. When the rotating speed of the cast iron pipe die driven by the main driving motor is reduced, the centrifugal force is reduced, so that the main magnet block slides back under the action of resilience force of the first connecting spring, the adsorbed iron sliding block is pulled to be separated from the auxiliary magnet block and extruded to the pressure sensing switch, then the position of the auxiliary driving motor is fixed, and after the auxiliary driving motor is started, the pressure sensing switch is pressed to the pressure sensing switch. The auxiliary driving gear drives the cast iron pipe die to continuously rotate at a certain rotating speed, rotating speed recovery and centrifugal force recovery are achieved, and cast iron pipe manufacturing can be continuously carried out conveniently.

Disclosed are crosslinked particles (e.g., microparticles) that are capable of storing and releasing drugs. The particles can be macroparticles, microparticles, or nanoparticles and can be composed of polyester backbones. The particles can be loaded with a drug. The particles can degrade in vivo to release the drug. The particles can be prepared by crosslinking functionalized polyester backbones and loaded with a given drug. The particles of the present disclosure can be injected with a syringe. In some embodiments, the particles of the present disclosure are administered in connection with a surgery and release the drug after the site of the surgery for a period of 1-6 months.